Oxra-S 10/100

Oxra-S 10/100 is used for managing type 2 diabetes by combining two active ingredients, Dapagliflozin (10mg) and Sitagliptin (100mg), that work through complementary mechanisms to improve blood glucose control. Dapagliflozin belongs to a class of medications called SGLT2 inhibitors, which help the kidneys remove excess glucose through urine, while Sitagliptin is a DPP-4 inhibitor that increases insulin release and decreases glucagon production when blood sugar levels are elevated. This dual-action combination provides effective glycemic management for adults whose diabetes is not adequately controlled with diet and exercise alone, and patients often monitor their progress using devices like OneTouch Ultra Test Strips for accurate blood glucose readings. Manufactured by Sun Pharmaceutical Industries Ltd, Oxra-S 10/100 offers a convenient once-daily tablet regimen, and those comparing combination therapies may also consider Janumet XR CP (Sitagliptin/Metformin), which pairs Sitagliptin with Metformin instead of Dapagliflozin.

Dosage & How to Take Oxra-S 10/100

Take Oxra-S 10/100 exactly as prescribed by your healthcare provider, typically one tablet once daily with or without food. The standard dosage is one 10mg/100mg tablet taken at the same time each day to maintain consistent blood sugar control. Swallow the tablet whole with a full glass of water, do not crush, chew, or split the tablet. Because Dapagliflozin increases urination, many patients find it helpful to take the medication in the morning to avoid nighttime bathroom trips. If you miss a dose, take it as soon as you remember unless it is almost time for your next scheduled dose; never double up to compensate for a missed tablet. Regular monitoring of blood glucose levels, kidney function, and overall diabetes management remains essential while using this medication.

Is Oxra-S 10/100 Right for You?

Oxra-S 10/100 is safe and appropriate for adults with type 2 diabetes who require combination therapy to achieve target blood glucose levels. This medication is particularly suitable for patients who have not achieved adequate control with single-agent therapy or who benefit from the complementary mechanisms of an SGLT2 inhibitor and DPP-4 inhibitor. However, Oxra-S 10/100 is not recommended for individuals with type 1 diabetes, diabetic ketoacidosis, severe kidney impairment (eGFR below 45 mL/min), or those on dialysis. Patients should inform their healthcare provider about any history of urinary tract infections, genital yeast infections, dehydration, low blood pressure, or liver disease before starting treatment. Some individuals exploring foundational diabetes therapies may start with Glycomet 250mg (Metformin) before advancing to combination options. Always consult your doctor to determine if Oxra-S 10/100 aligns with your specific diabetes management plan and medical history.

Buying Oxra-S 10/100 Online, USA, UK, Australia & Canada

SafeRxPills offers convenient access to Oxra-S 10/100 for customers in the United States, United Kingdom, Australia, and Canada, with discreet packaging and reliable delivery typically arriving within 7-14 business days. Our licensed online pharmacy ensures that every order is dispensed by qualified pharmacists and shipped directly to your door, eliminating the need for in-person pharmacy visits. We accept multiple secure payment methods and provide customer support to assist with questions about your diabetes medication regimen. Whether you're managing your condition with Oxra-S 10/100 alone or as part of a comprehensive treatment plan that includes lifestyle modifications and regular monitoring, SafeRxPills makes obtaining your prescription simple, private, and affordable across all four countries we serve.